Novanta/$NOVT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Novanta
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Ticker
$NOVT
Sector
Digital Hardware
Primary listing
Employees
3,000
Headquarters
Website
Novanta Metrics
BasicAdvanced
$5.8bn
114.32
$1.41
1.62
-
Price and volume
Market cap
$5.8bn
Beta
1.62
52-week high
$165.56
52-week low
$98.27
Average daily volume
451k
Financial strength
Current ratio
3.564
Quick ratio
2.549
Long term debt to equity
18.335
Total debt to equity
22.222
Interest coverage (TTM)
6.58%
Profitability
EBITDA (TTM)
178.808
Gross margin (TTM)
44.23%
Net profit margin (TTM)
5.35%
Operating margin (TTM)
11.57%
Effective tax rate (TTM)
22.79%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
4.56%
Return on equity (TTM)
5.16%
Valuation
Price to earnings (TTM)
114.325
Price to revenue (TTM)
6.057
Price to book
4.39
Price to tangible book (TTM)
11.56
Price to free cash flow (TTM)
88.868
Free cash flow yield (TTM)
1.13%
Free cash flow per share (TTM)
1.817
Growth
Revenue change (TTM)
5.59%
Earnings per share change (TTM)
-27.55%
3-year revenue growth (CAGR)
4.69%
10-year revenue growth (CAGR)
10.53%
3-year earnings per share growth (CAGR)
-11.53%
10-year earnings per share growth (CAGR)
3.83%
What the Analysts think about Novanta
Analyst ratings (Buy, Hold, Sell) for Novanta stock.
Novanta Financial Performance
Revenues and expenses
Novanta Earnings Performance
Company profitability
Novanta News
AllArticlesVideos
Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026
Business Wire·2 weeks ago
Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026
Business Wire·2 weeks ago
Novanta Q1 Earnings Call Highlights
MarketBeat·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs